BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20878267)

  • 21. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage.
    Switzer JA; Rocker J; Mohorn P; Waller JL; Hughes D; Bruno A; Nichols FT; Hess DC; Natarajan K; Fagan SC
    Stroke; 2012 Sep; 43(9):2500-2. PubMed ID: 22811449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
    Pabinger I; Brenner B; Kalina U; Knaub S; Nagy A; Ostermann H;
    J Thromb Haemost; 2008 Apr; 6(4):622-31. PubMed ID: 18208533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial.
    van Aart L; Eijkhout HW; Kamphuis JS; Dam M; Schattenkerk ME; Schouten TJ; Ploeger B; Strengers PF
    Thromb Res; 2006; 118(3):313-20. PubMed ID: 16182346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
    Huynh TK; Costello JL; Rebuck JA
    Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal.
    Zemrak W; Manuel F; Smith KE; Rolfe S; Hayes T; Trowbridge RL; Carlone B; Seder D
    J Thromb Thrombolysis; 2019 Feb; 47(2):263-271. PubMed ID: 30443817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy.
    Khorsand N; Kooistra HA; van Hest RM; Veeger NJ; Meijer K
    Thromb Res; 2015 Jan; 135(1):9-19. PubMed ID: 25480313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage.
    Imberti D; Barillari G; Biasioli C; Bianchi M; Contino L; Duce R; D'Incà M; Gnani MC; Mari E; Ageno W
    Blood Transfus; 2011 Apr; 9(2):148-55. PubMed ID: 21251465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal.
    Kerebel D; Joly LM; Honnart D; Schmidt J; Galanaud D; Negrier C; Kursten F; Coriat P;
    Crit Care; 2013 Jan; 17(1):R4. PubMed ID: 23305460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Comparison of Point-of-Care Device and Standard Analyzer for Monitoring of International Normalized Ratio in Outpatient Oral Anticoagulant Clinic.
    Moiz B; Rashid A; Hasan M; Jafri L; Raheem A
    Clin Appl Thromb Hemost; 2018 Oct; 24(7):1153-1158. PubMed ID: 29374969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.
    Rivosecchi RM; Durkin J; Okonkwo DO; Molyneaux BJ
    Neurocrit Care; 2016 Dec; 25(3):359-364. PubMed ID: 27076286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage.
    Vigué B; Ract C; Tremey B; Engrand N; Leblanc PE; Decaux A; Martin L; Benhamou D
    Intensive Care Med; 2007 Apr; 33(4):721-5. PubMed ID: 17260127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage.
    Imberti D; Barillari G; Biasioli C; Bianchi M; Contino L; Duce R; D'Incà M; Mameli L; Pinna L; Ageno W
    Pathophysiol Haemost Thromb; 2008; 36(5):259-65. PubMed ID: 19996636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of discrepancy between point-of-care and central laboratory international normalized ratio testing in ED patients with cerebrovascular disease.
    Nanduri S; Tayal AH; Hegde GG; Shang J; Venkat A
    Am J Emerg Med; 2012 Nov; 30(9):2025-9. PubMed ID: 22795413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin.
    Hoel RW; Albright RC; Beyer LK; Santrach PJ; Magtibay DL; Everson SL; McBane RD
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):99-104. PubMed ID: 18987294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-Factor Prothrombin Complex Concentrate Administration via Intraosseous Access for Urgent Reversal of Warfarin.
    Peyko V; Shams D; Urbanski R; Noga J
    J Emerg Med; 2019 Jul; 57(1):82-84. PubMed ID: 31060844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
    Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
    Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
    Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
    Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.